Stockreport

Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth? [Yahoo! Finance]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF after listing, if you had bought and held the shares since 1999, you would have made a fortune. Nonetheless, only a fool would ignore the risk that a loss making company [Read more]